| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911643 | Lung Cancer | 2005 | 8 Pages |
Abstract
The pretreatment VEGF serum level was identified as independent prognostic factor in this study and may help to assess individual risk and treatment profiles in patients with metastatic NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eckart Laack, Antje Scheffler, Iris Burkholder, Ina Boeters, Birte Andritzky, Gunter Schuch, Michael Görn, Gaby Vohwinkel, Lutz Edler, Walter Fiedler, Dieter Kurt Hossfeld,